Cannabis in Pro Sports: How NFL and NBA Athletes Are Choosing Weed Over Opioids
Advertisement
There's a quiet revolution happening in professional locker rooms across America. The same athletes who once risked fines, suspensions, and public shaming for using cannabis are now building weed empires, advocating for plant-based recovery, and participating in league-funded clinical trials. In 2026, cannabis isn't just tolerated in pro sports — it's becoming a cornerstone of athlete wellness.
Key Takeaways
- The NFL has funded $1 million in clinical trials studying cannabis for athlete pain management and neuroprotection
- 78% of athletes who use cannabis do so for pain management, not recreation — positioning it as a direct alternative to opioids
- The NBA removed marijuana from its drug testing program entirely in 2023, and over a dozen current and former players now run cannabis businesses
Table of Contents
- The NFL Puts $1 Million Behind Cannabis Research
- The NBA's Complete About-Face
- What Athletes Are Actually Using Cannabis For
- The Opioid Crisis That Changed Everything
- The Business of Athlete Cannabis Brands
- What This Means for Recreational Users
- The Road Ahead
The NFL Puts $1 Million Behind Cannabis Research
In what might be the most significant endorsement of cannabis in professional sports history, the NFL has committed $1 million to fund clinical trials studying the therapeutic efficacy of THC, CBD, and combined THC/CBD formulations for pain management in elite athletes.
The research isn't hypothetical — these are active clinical trials assessing whether cannabinoids can replace opioids for post-competition soft-tissue injury pain. A separate arm of the study investigates whether cannabis-based compounds offer neuroprotective properties that could reduce concussion severity, a holy grail for a league grappling with its CTE crisis.
This is the same league that once suspended players for an entire season over a positive marijuana test. The shift didn't happen overnight. In 2020, the NFL raised its THC testing threshold from 15 ng/mL to 150 ng/mL — a tenfold increase that effectively stopped penalizing casual use.
By 2026, the league is actively exploring whether the plant might save its players from the opioid dependency that has devastated so many careers.
The NBA's Complete About-Face
The NBA went even further. In its 2023 collective bargaining agreement, the league removed marijuana from its testing program entirely. No tests.
No thresholds. No consequences. Players are free to use cannabis however they choose during the season and offseason alike.
The impact has been immediate. A growing roster of active and retired NBA players have launched cannabis ventures, turning their personal advocacy into thriving businesses. Kevin Durant, Allen Iverson, Al Harrington, Dwyane Wade, Carmelo Anthony, John Wall, and more than a dozen others have invested in or founded cannabis companies.
Al Harrington's journey is particularly notable. The 16-year NBA veteran founded Viola, a cannabis brand named after his grandmother, after witnessing cannabis help her manage glaucoma symptoms when conventional medicine fell short. Viola now operates in multiple states and has become one of the most recognized minority-owned cannabis brands in the country.
What Athletes Are Actually Using Cannabis For
A common misconception is that athletes use cannabis recreationally — a post-game celebration or a way to unwind. The data tells a different story. Surveys of elite and retired athletes reveal that 78% use cannabis primarily for pain management, not recreation.
The specific use cases break down across several categories that matter deeply to professional athletes:
Pain and Inflammation Management. Cannabis compounds, particularly CBD and THC in combination, interact with the endocannabinoid system [Quick Definition: Your body's built-in network of receptors that interact with cannabinoids] to modulate inflammation and pain perception. For athletes dealing with chronic joint pain, muscle tears, and post-surgical recovery, this represents an alternative to NSAIDs and opioids — both of which carry significant long-term health risks.
Sleep Quality. Recovery happens during sleep, and sleep quality is arguably the single most important factor in athletic performance. Cannabis strains and products high in CBN and myrcene-rich terpene profiles are increasingly used by athletes to improve sleep onset and duration without the grogginess associated with pharmaceutical sleep aids.
Anxiety and Mental Health. The mental health burden on professional athletes — performance anxiety, media pressure, the psychological toll of injuries — is increasingly recognized. Cannabis, particularly CBD-dominant formulations, offers an alternative to benzodiazepines and SSRIs for managing acute anxiety without the dependency risks.
Muscle Recovery. Topical cannabis products — creams, balms, and transdermal patches — are now a standard part of many athletes' post-training routines. These products deliver localized anti-inflammatory and analgesic effects without psychoactive effects, making them practical for use between training sessions and competitions.
The Opioid Crisis That Changed Everything
To understand why cannabis has gained such rapid acceptance in professional sports, you have to understand the opioid crisis that preceded it. A landmark 2011 study in the journal Drug and Alcohol Dependence found that 52% of retired NFL players used opioids during their playing careers, and 71% reported misusing them.
The stories are devastating. Former players have spoken publicly about receiving prescriptions for Vicodin and Percocet like candy — sometimes dozens of pills at a time, with minimal medical oversight. Many transitioned to heroin or fentanyl when their prescriptions ended and their careers were over.
Cannabis offers something pharmaceutical painkillers cannot: effective pain management with virtually no risk of fatal overdose. No one has ever died from a cannabis overdose. For leagues that watched their former players spiral into addiction and, in too many cases, early death, that distinction matters enormously.
The Business of Athlete Cannabis Brands
The intersection of sports and cannabis has created a new category of celebrity branding. Unlike many celebrity cannabis ventures that amount to little more than licensing deals, several athlete-founded brands have built genuine operations with distinct product lines and market positions.
Shawn Kemp, the former Seattle SuperSonics star, opened a cannabis retail store in Seattle. Chris Webber launched Players Only, connecting cannabis products with sports culture. Isiah Thomas entered the market with partnerships focused on social equity [Quick Definition: License programs designed to help communities disproportionately harmed by the war on drugs] — a natural extension for athletes who have witnessed the disproportionate impact of cannabis criminalization on communities of color.
These ventures aren't just business plays. Many athlete-entrepreneurs are using their platforms to advocate for cannabis policy reform, expungement of cannabis convictions, and reinvestment in communities devastated by the war on drugs.
What This Means for Recreational Users
The normalization of cannabis in professional sports has a profound trickle-down effect on public perception. When the NFL — arguably America's most culturally influential sports league — funds cannabis research, it signals to mainstream America that this isn't a fringe substance used by counterculture rebels. It's a legitimate wellness tool.
For everyday cannabis users, athlete advocacy has also driven product innovation. The demand for precise dosing, fast-acting formulations, and targeted delivery systems in the athletic market has led to better products for everyone — from nano-emulsion edibles to high-quality topicals and CBD isolates.
The Road Ahead
The trajectory is clear. Professional sports leagues are moving from tolerance to active research and, potentially, to endorsement of cannabis as a legitimate recovery tool. The NFL's clinical trials are expected to produce their first results by late 2026 or early 2027, and those findings could reshape not just sports medicine but broader medical cannabis policy.
In the meantime, the sight of professional athletes openly advocating for cannabis — not from the shadows but from boardrooms and brand launches — continues to shift the cultural conversation. The stoner athlete stereotype is dead. In its place is a growing body of evidence, a roster of successful business ventures, and a fundamental rethinking of what recovery looks like in professional sports.
Pull-Quote Suggestions:
"In what might be the most significant endorsement of cannabis in professional sports history, the NFL has committed $1 million to fund clinical trials studying the therapeutic efficacy of THC, CBD, and combined THC/CBD formulations for pain management in elite athletes."
"A landmark 2011 study in the journal Drug and Alcohol Dependence found that 52% of retired NFL players used opioids during their playing careers, and 71% reported misusing them."
"There's a quiet revolution happening in professional locker rooms across America."
Why It Matters: From NFL-funded research to NBA entrepreneurs, cannabis is transforming athlete recovery. Discover how pro sports are embracing weed over opioids in 2026.